Glycogen synthase kinase‐3 beta (GSK‐3β) dysfunction may play an essential role in the
pathogenesis of psychiatric, metabolic, neurodegenerative diseases, in which oxidative …

Abstract Glycogen synthase kinase3 (GSK3) is emerging as a prominent drug target in the
CNS. The most exciting of the possibilities of GSK3 lies within the treatment of Alzheimer's …

ABSTRACT Glycogen synthase kinase‐3 (GSK3), particularly the isoform GSK3β, has been
implicated in a wide range of physiological systems and neurological disorders including …

Abstract Glycogen synthase kinase-3 (GSK-3) is a highly conserved and multifunctional
serine/threonine protein kinase widely distributed in eukaryotic cells. GSK-3 is originally …

Glycogen Synthase Kinase 3 (GSK3) is one of the Serine/Threonine protein kinases, which
has gained a lot of attention for its role in a variety of pathways. It has two isoforms, GSK3α …

Abstract Glycogen synthase kinase‐3 (GSK‐3) is a serine/threonine kinase regulating
diverse cellular functions including metabolism, transcription and cell survival. Numerous …

The PI3K-dependent activation of AKT results in the inhibition of GSK3β in most signaling
pathways. These kinases regulate multiple neuronal processes including the control of …

Abstract Glycogen synthase kinase 3 (GSK-3) is a serine/threonine kinase widely expressed
in various tissues and organs. Unlike other kinases, GSK-3 is active under resting conditions …

Glycogen synthase kinase‐3 (GSK‐3), an important component of the glycogen metabolism
pathway, is highly expressed in the CNS. It has been implicated in major neurological …

The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) is involved in a broad
range of cellular processes including cell proliferation, apoptosis and inflammation. It is now …